Predicting the future of health
Once infected by SARS-CoV-2, would you like to know your health status evolution? This is Biosfer Teslab commitment in the SARS-CoV-2 pandemic. The Spanish… Read More »Predicting the future of health
News
Alberto Elzaburu Foundation award
The sixth edition of the Alberto Elzaburu Foundation Innovation Award recognizes Núria Amigó, CEO of Biosfer Teslab, as a young entrepreneur The Alberto Elzaburu Foundation,… Read More »Alberto Elzaburu Foundation award
Biosfer Teslab presents its first industrial doctoral thesis
The student Rocío Fuertes has obtained a doctoral degree from the University Rovira i Virgili after defending her thesis “1H-NMR glycoprotein analysis: An Advanced approach… Read More »Biosfer Teslab presents its first industrial doctoral thesis
Disruptive innovations and start-ups
Last December, Núria Amigó took part in the round table on “Disruptive innovations and start-ups”. You can see her speech here (video in Catalan)
LDL cholesterol: the poison is stored in small bottles
Dr. Adriana Saltijeral of the University Hospital del Tajo (Aranjuez, Madrid) interviews Dr. Leopoldo Pérez de Isla, of the San Carlos Clinical Hospital of Madrid… Read More »LDL cholesterol: the poison is stored in small bottles
Standard values of number and size of lipoprotein particles per age and gender, using Nuclear Magnetic Resonance
The XXIX Convention of the Spanish Atherosclerosis Society (SEA) took place in Granada last May, and its scientific committee chose another of the I+D projects… Read More »Standard values of number and size of lipoprotein particles per age and gender, using Nuclear Magnetic Resonance
Metabolomics characterization for patients with Rheumatoid Arthritis using spectroscopy
In May, the XXIX Convention of the Spanish Atherosclerosis Society (SEA) took place in Granada, and its scientific committee chose one of the I+D projects… Read More »Metabolomics characterization for patients with Rheumatoid Arthritis using spectroscopy
Especialists ask for the use in clinical practise of the new Lipoprotein determination test
Biosfer Teslab took part in the XXIX National Convention of the Spanish Atherosclerosis Society (SEA), held this past May. Specifically, the Liposcale test was the… Read More »Especialists ask for the use in clinical practise of the new Lipoprotein determination test
Biosfer Teslab in the 8th National Cardiovascular Meeting of SEMERGEN
On the 21th of May, Biosfer Teslab took part in the 8th Cardiovascular Meeting of SEMERGEN, in Santander. Nuria Amigó took part in a session… Read More »Biosfer Teslab in the 8th National Cardiovascular Meeting of SEMERGEN
The Di@bet.es 2 study will define risk scales that will let us apply prevention programs for less people, but better targeted
The Research Program of CIBERDEM is focused on the study of the epidemiology of diabetes mellitus; genetics, epigenetics and related environmental factors with this pathology,… Read More »The Di@bet.es 2 study will define risk scales that will let us apply prevention programs for less people, but better targeted